In 2023, a Wall Street Journal investigation reported that more than 50 websites claimed to sell semaglutide and tirzepatide, with advertised prices of roughly $100–$200 per month. Those figures describe that investigation—not the number of sellers or prices in 2026. The central consumer-finance risk remains: a low advertised price from a seller that does not require a prescription is not evidence that the product is legitimate, safe, or a dependable way to save money.
What the 2023 report found—and what it did not establish
Futurism’s August 17, 2023 report on the Wall Street Journal investigation said more than 50 websites claimed to sell semaglutide and tirzepatide. Some advertised products as “pharmaceutical grade” or “for research purposes,” and the reported advertised prices were roughly $100–$200 per month. These were observations reported at the time, not verified offers or a current market survey. Futurism’s 2023 report
The same report described sellers whose pages disclaimed human use while also providing human dosage directions. A “research use only” label does not demonstrate that a product is safe or appropriate for a person to use. The report does not establish how many such sites operate now, whether their offers are genuine, or what they currently charge.
Why a cheap no-prescription offer can cost more than it appears
For personal finances, the advertised price is only one part of the risk. A seller outside a legitimate prescription and pharmacy process may leave a buyer unable to verify what is in the product, how it was handled, or whether the stated amount is accurate. If the product is counterfeit, mislabeled, or improperly measured, the apparent savings do not account for potential medical harm or the cost of dealing with it.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
FDA advises consumers to obtain Ozempic with a valid prescription through a state-licensed pharmacy. The agency has identified counterfeit Ozempic in the U.S. supply chain and warns consumers not to use products identified as counterfeit. FDA consumer and provider safety information
Approved medicines, compounded products, and unauthorized online offers
These routes are not interchangeable. FDA-approved semaglutide medicines have gone through FDA review and are obtained with a valid prescription from a licensed pharmacy. Compounded drugs are not FDA-approved and are not the same as FDA-approved generic drugs. A product offered without a prescription, especially one described only as a research product, is not made trustworthy by its price or marketing language.
Rank #2
| Route | FDA status and access | What to consider |
|---|---|---|
| FDA-approved semaglutide medicine | FDA-approved medicine; FDA advises obtaining Ozempic with a valid prescription through a state-licensed pharmacy. | The prescription and licensed-pharmacy route provides a way to verify the medicine’s source. It does not mean every online seller is legitimate. |
| Compounded semaglutide | Compounded drugs are not FDA-approved. Compounding is subject to statutory conditions, not a general substitute for approved medicines. | Product concentrations and measurement can vary; FDA has received dosing-error reports involving compounded injections. |
| Unauthorized or “research use only” online offer | A seller’s label or claim does not establish FDA approval, lawful dispensing, or suitability for human use. | Without a valid prescription and verifiable pharmacy source, the buyer may not be able to establish product identity or reliability. |
Compounded semaglutide: dosing and product-identity concerns
FDA reports that compounded injectable semaglutide can come in varying concentrations and multi-dose vials. Confusion among milligrams, milliliters, and “units,” along with calculation mistakes by patients or providers, has been linked to dosing errors. Some reports involved doses five to 20 times the intended amount; reported effects included gastrointestinal symptoms and, in some cases, medical attention or hospitalization. This is a safety warning, not a basis for calculating or adjusting a dose. FDA information on dosing errors
As of May 31, 2026, FDA reported 990 adverse-event reports associated with compounded semaglutide. That is a count of reports, not an incidence rate: FDA says reports are likely undercounted because many state-licensed pharmacies are not required to submit them, and it is not always possible to determine whether the drug caused a reported event. FDA compounded-semaglutide information
Quick wins for a faster PC:
Clear out junk files and repair common Windows errorsFree Scan →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Product identity matters, too. Semaglutide sodium and semaglutide acetate are different active ingredients from the semaglutide in approved medicines. FDA says it is unaware of a lawful basis for compounding with these salt forms. FDA compounded-semaglutide information
What changed after the 2023 seller report
FDA determined that the shortage of semaglutide injection products was resolved on February 21, 2025. In an April 2026 reminder, the agency said compounding remains subject to statutory conditions. For section 503A, a drug must be compounded for an individual patient based on a prescription; compounders generally may not regularly or in inordinate amounts make products that are essentially copies of commercially available drugs. Compounding is therefore not a general way to bypass approval or prescription requirements. FDA clarification on compounding policies
Rank #4
FDA also announced in February 2026 that it intended to take action to restrict GLP-1 active pharmaceutical ingredients for non-FDA-approved compounded drugs mass-marketed as alternatives. In March 2026, it announced warning letters to 30 telehealth firms over allegedly false or misleading marketing claims for compounded GLP-1 products. Those dated actions concern the specified ingredients and marketing claims; they do not establish that every telehealth provider or every compounded prescription is unlawful. FDA February 2026 announcement · FDA March 2026 announcement
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How to assess an online offer without relying on its headline price
- Check whether a valid prescription is required. An offer to sell prescription medicine without one is a warning sign, not a bargain.
- Verify the pharmacy. For Ozempic, FDA advises using a state-licensed pharmacy and warns against products identified as counterfeit.
- Do not treat disclaimers as proof. “Research use only,” “pharmaceutical grade,” or dosing directions on a seller’s page do not establish safety or suitability for human use.
- Distinguish the product. FDA-approved medicines, compounded drugs, and research-labeled or unauthorized products have different approval and oversight status.
- Ask a licensed clinician about legitimate treatment options. A clinician can evaluate whether a medicine is appropriate and explain the prescription route; this article does not endorse a particular provider or seller.
What the historical prices mean for a budget
The roughly $100–$200 monthly figures reported in 2023 were advertised prices described by Futurism, not verified prices and not a reliable estimate for 2026. No current count of no-prescription seller sites or current price range is established here. Do not build a treatment budget around an unverified listing: the number on a page cannot tell you whether the seller will deliver an authentic product, whether the product is usable, or what financial consequences could follow from an unsafe one.
Do these 3 things before closing this tab:
1Clear out junk files and repair common Windows errors2Fix the driver behind crashes, sound loss and screen glitches3Repair Windows errors before they cause bigger problemsQuick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
